Day: May 19, 2022

Posted on

Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics

Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range

Rijswijk, The Netherlands, May 19, 2022 (GLOBE NEWSWIRE) —

Summary

  • Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial resistance
  • The company is the first to publicly announce that Its entire supply chain of oral antibiotics – including its own and supplier manufacturing sites – is fully compliant with the stringent Predicted No Effect Concentration (PNEC) discharge targets set by the AMR Industry Alliance
  • This achievement demonstrates Centrient Pharmaceuticals’ commitment and leadership in the responsible production of antibiotics.

Centrient Pharmaceuticals announces 100% compliance with the stringent Predicted No Effect Concentration (PNEC) discharge targets set by the AMR Industry Alliance for clean manufacturing of its full oral antibiotics product range. This standard covers both Centrient’s sites and its suppliers’ sites. This achievement positions the company as a frontrunner in the industry with the delivery of responsibly-produced antibiotics, which minimize the possible contribution to antimicrobial resistance.

The PNEC discharge target is the concentration of an antibiotic in water at which there is unlikely to be a risk of adverse environmental effects or of antimicrobial resistance (AMR) developing. These scientific, risk-based targets were developed by the AMR Industry Alliance and cover around 120 active pharmaceutical ingredients (APIs) used in antibiotic manufacturing. Each individual antibiotic has a corresponding PNEC value, published in the AMR Industry Alliance table of Recommended PNECs for Risk Assessments (updated periodically).

High concentrations of antibiotic residues in factory wastewater can create hotspots of resistant bacteria which may lead to AMR. While manufacturing is just one of the contributors to the emergence of AMR in the environment, its impact cannot be overlooked. AMR is a major threat to global public health as well as to the healthcare industry. Many standard medical procedures such as organ transplants, chemotherapy, and surgeries such as caesarean sections become much more dangerous without effective antibiotics to prevent and treat infections. Antibiotics are the cornerstone of our modern healthcare system, and complying with PNEC standards enables manufacturers to ensure supply of these critically important medicines does not contribute to the risk of AMR.

The PNEC values are increasingly being recognized as the standard for antibiotic discharge concentrations in water and are expanding beyond Alliance companies and their supply chains. For example, tenders in the UK and Germany (health insurer AOK) include a specific reference to the PNEC discharge targets. Also, companies assessed externally by organizations such as the Access to Medicine Foundation will have public exposure for their performance on PNECs.

As a strong advocate for sustainable manufacturing, Centrient Pharmaceuticals became a founding board member of the AMR Industry Alliance in 2017, working with partners to raise awareness and deliver solutions to the AMR issue. Since then, the company’s own journey to reaching full compliance has included establishing state-of-the-art wastewater treatment facilities at all their sites worldwide and developing tests for measuring antibiotic activity in wastewater streams, leading to a fully clean and PNEC-compliant supply chain.

“We are proud to be the first in our industry to publicly announce PNEC compliance for our oral antibiotics product supply chain.

At Centrient Pharmaceuticals, our commitment to Sustainability is in our DNA – we ensure that the way in which we produce pharmaceuticals has the lowest environmental impact and does not contribute to AMR. We are proud of our PureActives® enzymatic low-carbon technology, ISO 14001 certification of all our sites, and Board positions at the Pharmaceutical Supply Chain Initiative and AMR Industry Alliance.

We will continue to work with customers, suppliers, industry and government decision-makers across the value chain to make the supply and buying of antibiotics sustainable to curb AMR.”, says Rex Clements, CEO at Centrient Pharmaceuticals.

Read our whitepaper ‘Manufacturing sustainable antibiotics for the future’ here.

About Centrient Pharmaceuticals

Centrient Pharmaceuticals is the global leader in the production and commercialisation of sustainable antibiotics, next-generation statins, and anti-fungals. We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.

We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 2,200 employees work continuously to meet our customers’ needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance.

Founded 150 years ago as the ‘Nederlandsche Gist- en Spiritusfabriek’, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rijswijk (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, the United States and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital Private Equity, a leading global private investment firm.

For more information please visit www.centrient.com or contact Centrient Pharmaceuticals Corporate Communications, Alice Beijersbergen, Director Branding & Communications. E-Mail: alice.beijersbergen@centrient.com.
About the AMR Industry Alliance

The AMR Industry Alliance was formed in 2017. With approximately 100 life sciences companies and trade associations, it represents nearly one-third of the volume of sales and the majority of all novel products. Members have committed to report on activities they are undertaking in the areas of research & science, access to antibiotics and appropriate use of these, as well as responsible environmental manufacturing to tackle the rapid spread of antimicrobial resistance. If AMR remains unchecked, the annual death toll could climb from 700,000 each year to 10 million by 2050 and the economic impacts could be on par with those of the 2008 financial crisis. The AMR Industry Alliance ensures that signatories collectively deliver on the specific commitments made in the Industry Declaration on AMR and the Roadmap for Progress on Combating AMR and measures progress made in the fight against AMR.
Forward-looking statements

This press release may contain forward-looking statements with respect to Centrient Pharmaceuticals’ future financial performance and position. Such statements are based on current expectations, estimates and projections of Centrient and information currently available to the company. Centrient cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. Centrient has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is governing.

Alice Beijersbergen
Centrient Pharmaceuticals
+31 (6) 823 579 56
alice.beijersbergen@centrient.com
Posted on

CGTN: China reaffirms commitment to high-standard opening-up

BEIJING, May 19, 2022 /PRNewswire/ — China on Wednesday reaffirmed its commitment to high-standard opening-up and pledged to foster a business environment based on market principles.

“I wish to reiterate that China’s resolve to open up at a high standard will not change, and that the door of China will open still wider to the world,” Chinese President Xi Jinping said when addressing the conference of the 70th anniversary of the China Council for the Promotion of International Trade (CCPIT) and the Global Trade and Investment Promotion Summit via video link.

“China will continue to foster an enabling business environment that is based on market principles, governed by law and up to international standards,” Xi said.

The world’s second-largest economy will pursue high-standard implementation of the Regional Comprehensive Economic Partnership (RCEP) agreement and high-quality Belt and Road cooperation and offer more market, investment and growth opportunities to the global business community, he said.

Despite challenges posed by the prolonged COVID-19 pandemic, China achieved a strong trade performance in the first quarter of the year, with total goods imports and exports surging 29.2 percent year on year to 8.47 trillion yuan (about $1.25 trillion), data from General Administration of Customs showed.

In the first quarter, China’s trade with countries along the Belt and Road rose 21.4 percent year on year to reach 2.5 trillion yuan (about $370 billion). The country’s trade with the other 14 RCEP members amounted to 2.67 trillion yuan (about $395 billion), up 22.9 percent year on year and accounting for 31.5 percent of its total imports and exports during the period.

Since its establishment in 1952, the CCPIT has played an important role in strengthening the bond of interests between Chinese and foreign enterprises, promoting international economic and trade exchanges and promoting the development of relations, Xi said.

The 70-year journey of the CCPIT has been “an epitome of China’s ever-expanding opening-up endeavor, and an important witness of how businesses from different countries could share in development opportunities and benefit from win-win cooperation,” he added.

Xi calls for making ‘pie’ of cooperation bigger

Noting that economic globalization is experiencing headwinds and the world is entering a new period of volatility and transformation, the president made several proposals.

Joint efforts are needed in defeating the pandemic, he said, adding that it is important to put people and their lives first, actively engage in international cooperation on vaccine R&D, production and distribution, and bolster global public health governance.

On reinvigorating trade and investment, he stressed supporting the World Trade Organization (WTO)-centered multilateral trading regime, ensuring security and stability of the global industrial and supply chains, and making the “pie” of cooperation bigger to allow development gains to better trickle down to people of all countries.

He also emphasized the efforts to unleash the power of innovation in driving development, calling for fostering an open, fair, equitable and non-discriminatory environment for scientific and technological development.

On improving global governance, he said true multilateralism must be upheld.

“We should choose dialogue over confrontation, tear down walls rather than erect walls, pursue integration instead of decoupling, opt for inclusiveness, not exclusion, and guide reforms of the global governance system with the principle of fairness and justice,” he said.

https://news.cgtn.com/news/2022-05-18/President-Xi-reiterates-China-s-resolve-to-open-up-at-high-standard-1a8MutaXcli/index.html

Posted on

Mainz Biomed & Dante Labs Announce Partnership for the Commercialization of ColoAlert in Europe and the United Arab Emirates (UAE)

  • Dante Labs is a Global Leader in Genomics and Precision Medicine
  • Mainz is Exclusively Focused on Developing Next Generation Diagnostics for the Early Detection of Cancer

BERKELEY, Calif. and MAINZ, Germany and NEW YORK, May 19, 2022 (GLOBE NEWSWIRE) — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer and Dante Labs, a global leader in genomics and precision medicine, announced today a partnership for the commercialization of ColoAlert in Italy and the United Arab Emirates (UAE). ColoAlert is Mainz’s flagship product, a highly efficacious and easy to use at-home detection test for colorectal cancer (CRC).

Dante Labs is a global leader in genome sequencing with a product development and commercial franchise focused on providing personalized preventive healthcare solutions by leveraging its robust databases and proprietary software platform to offer next-generation diagnostic tools direct to consumers and healthcare professionals. Inherent to Dante Lab’s business model is managing state-of-the-art genomic sequencing laboratories in multiple international regions, and operating a robust e-commerce platform.

“As a young company with the goal of bringing to market important diagnostic tools to help treat and prevent cancer indications, it’s an absolute pleasure to partner with an industry leader such as Dante Labs,” commented Guido Baechler, Chief Executive Officer of Mainz Biomed. “Our differentiated commercial plan of partnering with third-party laboratories for test kit processing versus the traditional methodology of operating a single facility requires alliances with like-minded companies such as Dante Labs, who share our passion for forward-thinking diagnostic test development and marketing strategies.”

The partnership will first launch ColoAlert in Italy and UAE using Dante’s various established commercial channels. Samples will initially be processed at Mainz’s in-house facility and then Dante will purchase Mainz’s CE-IVD polymerase chain reaction (PCR) assay kits and transition all test processing to Dante’s wholly-owned automated genomic sequencing laboratories in Italy (Europe) and Dubai (UAE) to offer localized service and support.

“We are excited by the opportunity to align with Mainz and represent ColoAlert in these initial markets,” commented Andrea Riposati, Chief Executive Officer of Dante Labs. “Both the product and the Company mirror our mission to develop and market top-tier preventive health solutions and use new channels to make innovative tests available to more patients around the world. With the launch of our enhanced ecommerce platforms for advanced diagnostics, ColoAlert is an amazing product to deliver more personalized medicine.”

ColoAlert is currently marketed across Europe, and the partnership with Dante Labs marks the test’s initial launch in the Middle East. Mainz will continue to develop commercial and R&D partnerships with companies that lead the field of health screening with a particular focus on stool diagnostics.

About ColoAlert

ColoAlert detects colorectal cancer (CRC) via a simple-to-administer test with a sensitivity and specificity nearly as high as the invasive colonoscopy*. The test utilizes proprietary methods to analyze cell DNA for specific tumor markers combined with the fecal immunochemical test (FIT) and is designed to detect tumor DNA and CRC cases in their earliest stages. The product is CE-IVD marked (complying with EU safety, health and environmental requirements) and is transitioning to compliance with IVDR. The product is commercially available in a selection of countries in the Europe Union. Mainz Biomed currently distributes ColoAlert through a number of clinical affiliates. Once approved in the U.S., the Company’s commercial strategy is to establish scalable distribution through a collaborative partner program with regional and national laboratory service providers across the country.

*Dollinger MM et al. (2018)

About Colorectal Cancer

Colorectal cancer (CRC) is the second most lethal cancer in the U.S. and Europe, but also the most preventable with early detection providing survival rates above 90%. Annual testing costs per patient are minimal, especially when compared to late-stage treatments of CRC which cost patients an average of $38,469 per year. The American Cancer Society estimated that in 2021 there were approximately 149,500 new cases of colon and rectal cancer in the U.S. with 52,980 resulting in death. Recent FDA decisions suggest that screening with stool DNA tests such as ColoAlert in the US should be conducted once every three years starting at age 45. Currently there are 112 million Americans aged 50+, a total that is expected to increase to 157 million within 10 years. Appropriately testing these US-based 50+ populations every three years as prescribed equates to a US market opportunity of approximately $3.7 Billion per year.

About Mainz Biomed N.V.

Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. ColoAlert is currently marketed across Europe with FDA clinical study and submission process intended to be launched in the first half of 2022 for U.S. regulatory approval. Mainz Biomed’s product candidate portfolio includes PancAlert, an early-stage pancreatic cancer screening test based on Real-Time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples, and the GenoStick technology, a platform being developed to detect pathogens on a molecular genetic basis.

For more information please visit www.mainzbiomed.com

For media enquiries, please contact [email protected]

For investor enquiries, please contact [email protected]

About Dante Labs
Dante Labs is a global genomic information company building and commercializing a new class of transformative health and longevity applications based on whole genome sequencing and AI. The Company uses its platform to deliver better patient outcomes from diagnostics to therapeutics with assets including one of the largest private genome databases with research consent, proprietary software designed to unleash the power of genomic data at scale and proprietary processes which enable an industrial approach to genomic sequencing.

Contact:

Laura D’Angelo
VP of Investor Relations
[email protected]
+39 0862 191 0671
www.dantelabs.com

Forward-Looking Statements

Certain statements made in this press release are “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements reflect the current analysis of existing information and are subject to various risks and uncertainties. As a result, caution must be exercised in relying on forward-looking statements. Due to known and unknown risks, actual results may differ materially from the Company’s expectations or projections. The following factors, among others, could cause actual results to differ materially from those described in these forward-looking statements: (i) the failure to meet projected development and related targets; (ii) changes in applicable laws or regulations; (iii) the effect of the COVID-19 pandemic on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the “SEC”) by the Company. Additional information concerning these and other factors that may impact the Company’s expectations and projections can be found in its initial filings with the SEC, including its Prospectus filed on October 12, 2021 and amended on October 25, 2021 and November 1, 2021 as well as the Prospectus filed on January 21, 2022. The Company’s SEC filings are available publicly on the SEC’s website at www.sec.gov. Any forward-looking statement made by us in this press release is based only on information currently available to Mainz Biomed and speaks only as of the date on which it is made. Mainz Biomed undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required by law.

Posted on

Global Fishing Watch welcomes partnership with Benin to combat illegal fishing

Collaboration on open data and technology to bolster maritime surveillance in West Africa

London, United Kingdom, May 18, 2022 (GLOBE NEWSWIRE) — LONDON, May 19, 2022 – A new partnership agreement between Benin and Global Fishing Watch aims to strengthen monitoring, control and surveillance of fishing activities within the waters of the West African State.

Under the memorandum of understanding, Global Fishing Watch will provide technical support, including fisheries analysis, capacity building and training on its vessel monitoring tools. To track its fishing fleet, Benin is establishing a vessel monitoring system, or VMS, and has formally agreed to share its data via the Global Fishing Watch map—the first African nation to commit to making its fishing fleet publicly visible.

Benin recently hosted in the large port city of Cotonou the first workshop under the new partnership, bringing together participants from Global Fishing Watch and various government agencies to develop actions to combat illegal, unreported and unregulated (IUU) fishing and advance collaboration through open and shared data.

“We are committed to eradicating illegal fishing from our waters and taking all action necessary to secure sustainable fisheries,” said the Honorable Gaston Cossi Dossouhoui, Minister for Agriculture, Livestock and Fisheries, Benin. “Through our partnership with Global Fishing Watch, we can strengthen our ability to monitor fishing activity, enforce the law and demonstrate our commitment to transparency in support of a blue economy. We encourage other African States to join us in this initiative to rid our waters of illicit activity.”

Captain (Navy) Fernand Maxime Ahoyo, Maritime Prefect of Benin added, “Global Fishing Watch’s tools will reinforce Benin’s actions to protect its maritime area.” Captain Ahoyo also acknowledged support from the non-profit organization, EcoBenin in facilitating engagement between the government of Benin and Global Fishing Watch.

“Greater transparency in fishing activity is an effective and cost-efficient means of driving more compliant behavior at sea. It allows law-abiding fishers to be rewarded, while those with missing information can be investigated and enforcement action more targeted,” said Dame Mboup, Global Fishing Watch’s program manager for West and Central Africa. “Violations by unauthorized vessels are prevalent off West Africa’s coast; Benin is demonstrating leadership in using cutting-edge technology and open data to combat illegal fishing.”

Persistent IUU fishing represents a considerable challenge for Benin and other coastal States in the Gulf of Guinea—a vast and diverse region spanning approximately 3,500 miles (5,633 kilometers) of coastline from Senegal to Angola. IUU fishing accounts for nearly 40 percent of all the fish caught in West Africa and threatens the ability of the region’s developing countries to maximize the use of their ocean resources.

In addition to the partnership with Benin, Global Fishing Watch has signed letters of intent with Cameroon, Gabon, Guinea, Mauritania and Senegal to strengthen collaboration on governance tools, capacity transfer and analysis. The Regional Fisheries Commission for the Gulf of Guinea and the Sub-regional Fisheries Commission have also expressed their interest in joining Global Fishing Watch’s vision for greater fisheries transparency, recognizing that regional cooperation and information sharing is needed to combat IUU fishing.

“West African countries rely on fish as a vital source of protein, income and employment for nearly 7 million people. But this region has seen its fish stocks decline drastically,” added Dame Mboup. “Regional collaboration is critical to eliminate IUU fishing and restore fish populations. Global Fishing Watch is excited to support a growing number of West African States working together to share fishing data and harness technology to safeguard their marine resources and promote economic security.”

Countries in the Gulf of Guinea recently stepped up the fight against IUU fishing and related crimes. Benin, Côte d’Ivoire, Ghana, Liberia, Nigeria and Togo, through the Fisheries Committee for the West Central Gulf of Guinea (FCWC)—an intergovernmental organization that promotes regional cooperation in fisheries management—launched the Regional Monitoring, Control and Surveillance Center to monitor fishing and related activities in the Gulf of Guinea.

In support of regional efforts to combat IUU fishing, Global Fishing Watch and the international nonprofit, TM-Tracking launched a pilot project with Côte d’Ivoire, Ghana, Kenya, Senegal and the FCWC to provide authorities with satellite tracking data, analysis and training needed to assess a fishing vessel’s recent operations and compliance risk. The collaboration will harness a new tool called vessel viewer, which was developed by the two organizations and provides vital information on a vessel’s identity, fishing activity, port visits and transshipments to help assess the need for inspection and port access.

With support from the Bloomberg Philanthropies, Moore Foundation, OAK Foundation and Oceans 5, Global Fishing Watch is committed to working with States to publicly share their vessel monitoring data and make its analytical tools and innovative technologies available to help enhance maritime surveillance.

“Achieving sustainable and equitable management of fisheries is critical,” said Melissa Wright, Vibrant Oceans Initiative Lead at Bloomberg Philanthropies. “Fisheries support the health and well-being of coastal communities, and Bloomberg Philanthropies is excited for the opportunity to expand the number of organizations that make fishing information available and accessible to governments, civil society and the public. This is an important step in the fight against illegal fishing – a problem that requires all hands on deck.”

Global Fishing Watch is an international nonprofit organization dedicated to advancing ocean governance through increased transparency of human activity at sea. By creating and publicly sharing map visualizations, data and analysis tools, we aim to enable scientific research and transform the way our ocean is managed. We believe human activity at sea should be public knowledge in order to safeguard the global ocean for the common good of all. 

Attachment

Sarah Bladen
Global Fishing Watch
+44 79 20333832
[email protected]
Posted on

Advance Local is New Sophi.io Customer

TORONTO, May 18, 2022 (GLOBE NEWSWIRE) — Advance Local, one of the largest media groups in the United States operating 10 leading news and information organizations and reaching 55 million people monthly, has quadrupled their subscription goal using Sophi Content Paywall Engine. Faced with advertising pressures exacerbated by the Coronavirus, Advance Local increased subscription conversions 45% using Sophi.io, an AI-powered automation, optimization and prediction platform developed by The Globe and Mail. Their success with Sophi has also earned them a spot as a finalist in the Digiday Media Awards, announced this week.

Neil Katz, Chief Customer Officer at Advance Local, said, “We wanted to see how much farther Sophi could take us, so we tested Sophi Content Paywall on one of our largest sites. The results were transformative. We were hoping for a 10% lift in conversion rate and Sophi delivered four times that result. We’re continuing to roll out Sophi solutions across more of our sites as we speak.”

Advance started using Sophi Content Paywall Engine on one of its largest sites, cleveland.com, to get better insights into the value of their content and fuel their new subscription business. The technology uses advanced natural language processing (NLP) to analyze every piece of content and select which articles to put behind a paywall. It picks only those articles where the subscription revenue opportunity outweighs the advertising revenue forgone.

During an experiment where Advance could see how Sophi performed side by side with their existing paywall, Sophi presented roughly the same amount of paywalls and generated a 45% lift in the total conversion rate, while also uncovering pockets of content that editors didn’t anticipate would generate subscriptions.

John Hassell, Senior Vice President and Editorial Director at Advance Local, said, “We wanted to see if Sophi’s content paywall could increase subscriber acquisition by 10% and it blew that goal out of the water. We’re feeling good about the platform and the way it is showing us just how valuable our editorial content is to our audience.”

Advance Local is also a finalist in the Digiday Media Awards, in the category of Best Subscription or Membership Product, for their work using Sophi Content Paywall Engine.

“Advance Local is an incredibly innovative organization that we’ve watched push the boundaries and we’re very excited to be working with them,” said Mike O’Neill, Co-Founder and CEO of Sophi.io. “We’re seeing great value come from the content paywall they’ve implemented and we’re excited to introduce some other cutting edge technology into this very strong brand.”

About Advance Local

Advance Local (www.advancelocal.com) is one of the largest media groups in the United States. It operates 10 leading news and information organizations and reaches 55 million people monthly across multiple platforms with its high-quality journalism. They are dedicated to unrivaled local journalism that improves the lives of millions of people.

About Sophi.io

Sophi.io (https://www.sophi.io) was developed by The Globe and Mail to help content publishers make important strategic and tactical decisions. It is a suite of AI and ML-powered automation, optimization and prediction solutions that include Sophi Site Automation, Sophi for Paywalls and Sophi for First Party Data. Sophi also powers one-click automated laydown of template-free print publishing. Sophi is designed to improve the metrics that matter most to your business, such as subscriber retention and acquisition, engagement, recency, frequency and volume.

Contact Us

Jamie Rubenovitch
Head of Marketing, Sophi.io
The Globe and Mail        
[email protected]
416-585-3355
Posted on

Openbravo signs a distribution contract with Hardis Group to accelerate retailers’ unified commerce strategies

LILLE, France, May 19, 2022 /PRNewswire/ — Openbravo, the Spanish vendor of a unified commerce platform for agile and innovative commerce, is implementing an ambitious indirect distribution strategy to support its growth in France, especially in the mid-market segment. The company has signed a major partnership with Hardis Group, IT consulting and services company, integrator, logistics software vendor and a specialist in the acceleration of digital commerce in B2B, B2C and D2C. Hardis Group will act as integrator and distributor of Openbravo’s unified commerce platform for customer experience improvement.

Hardis Group Logo

After a period of constant development following the opening of its French subsidiary 4 years ago and with a growing portfolio of references, Openbravo is now opening an indirect sales channel with partners offering high added value to establish its presence on the national territory. Openbravo provides software development and hosting, while its partners manage integration and consulting.

Hardis Group recently launched a Digital Commerce activity and aims to support companies across their entire digital commerce strategy. The group offers ‘end-to-end’ support, from omnichannel strategy consulting to the integration and operation of ‘composable’ information systems to accelerate digital commerce. Thanks to the Openbravo’s unified commerce platform, Hardis Group enables retailers to benefit from a fluid solution.

Openbravo Logo

Hardis Group has chosen Openbravo for its ability to provide an appropriate response to the retail challenges of omnichannel commerce to promote collaboration and to improve the customer experience. This partnership is also based on shared values such as allowing users to focus on the essentials (their business, agility and operational performance) thanks to intuitive mobile solutions. It has been formalized by signing a Business Alliance contract.

“Today, Openbravo directly manages key accounts and strategic retail accounts. In order to continue to address the mid-market, it was essential to rely on integrator partners with strong business expertise in retail. This partnership with Hardis is the concrete expression of a common desire, and the result of a fruitful collaboration on several projects” comments Christophe Dubuis, Sales Director for France and Northern Europe at Openbravo.

“Our teams are enthusiastic about the idea of taking on new challenges with Openbravo and are confident of the success of this collaboration, bringing together specialists with strong skills in a buoyant market. Openbravo provides real answers to the retailers and eCommerce players and allows us to propose the building blocks that were missing from our offer.” says Yohann Durand, Director of the Ile-de-France and North branch at Hardis Group.

About Openbravo

Openbravo is the software platform of choice for brands and retailers looking to accelerate their unified commerce strategy and increase the agility of their operations. It is a fully modular platform that integrates the online and offline channels and provides intelligent order management, a single, real-time view of customers and inventory, and a complete store solution to deliver more personalized and convenient experiences. It is an all-in-one cloud-based solution.

International clients such as BUT, Decathlon, Norauto, Sharaf DG, Toys ‘R’ Us Iberia and Zôdio prefer Openbravo, which is today used by more than 10,000 back office users and in more than 40,000 points of sale in more than 50 countries. To learn more, visit openbravo.com.

About Hardis

Hardis Group is an IT consulting and services company, Salesforce integrator and logistics software publisher with a mission to accelerate the transformation of commerce, the supply chain and information systems, particularly through cloud technologies. Its 1,235 employees support the strategic, organizational and technological transformations of companies throughout Europe, in order to develop their competitiveness, productivity and attractiveness.

Hardis Group had a turnover of 132.7 million euros in 2021. The company is in Grenoble (headquarters), Paris, Lyon, Lille, Nantes, Bordeaux, Madrid, Utrecht and Warsaw.

Logo – https://mma.prnewswire.com/media/1821118/Hardis_Group_Logo.jpg
Logo – https://mma.prnewswire.com/media/703504/Openbravo_Logo.jpg

Contact:
Xavier Places
Marketing Director
+34 607 676 568
[email protected]

 

 

Posted on

‫تحرر JA Solar الوحدة الكهروضوئية من النوع N DeepBlue 4.0 X

بكين، 19 مايو 2022 / PRNewswire / — تحتفل JA Solar بحدث إطلاق منتجاتها الجديدة لعام 2022 في 18 مايو، مع إطلاق أول وحدة كهروضوئية من النوع n DeepBlue 4.0 X . يمثل هذا العرض الجديد المبتكر أول دخول للشركة في سوق المنتجات الكهروضوئية من النوع n .

JA Solar new product DeepBlue 4.0 X

استنادًا إلى 182 رقاقة، التي تتميز بسلسلة التوريد الأكثر نضجًا والتعرف على مستوى الصناعة، تتضمن سلسلة DeepBlue 4.0 X ثلاثة أنواع من الوحدات قابلة للتكيف مع أي سيناريو: وحدة مكونة من 54 خلية للأنظمة الكهروضوئية السكنية، و 72 خلية و 78 خلية للمشاريع الكهروضوئية التجارية والخدمية. اجتازت DeepBlue 4.0 X بالفعل اختبارات IEC 61215 و IEC 61730 وحصلت على شهادة TÜV SÜD ، كما اجتازت اختبار ضباب الملح والأمونيا والرمل والغبار، مما يثبت ملاءمتها عبر مختلف التطبيقات والبيئات.

بالإضافة إلى المزايا المرحلة من وحدات DeepBlue 3.0 النمطية، تدمج DeepBlue 4.0 X أحدث التقنيات من JA Solar ، بما في ذلك خلية Bycium+ ، حيث يمكن أن تصل كفاءة الإنتاج الكتلي إلى أكثر من 24.8% بسبب ركيزتها وبنيتها عالية الجودة. أيضًا، تم تجهيز DeepBlue 4.0 X بتقنية التغليف عالية الكثافة الحاصلة على براءة اختراع GFI (التوصيل البيني المرن بدون فجوة)، حيث يتعامل تصميم الشريط المستدير مع المعالجة المؤقتة ومواد التغليف المحسنة مع الإجهاد الميكانيكي عند وصلات الخلايا البينية وبالتالي القضاء على خطر التكسير الدقيق. معًا، تجلب هذه موثوقية أعلى وإنتاجية أعلى للطاقة إلى DeepBlue 4.0 X ، مع أقصى طاقة تصل إلى 625 واط وكفاءة تصل إلى 22.4%.

 وفقًا لـ Kun Tang ، مدير قسم تكنولوجيا المنتجات في JA Solar ، تعمل JA Solar على التكنولوجيا من النوع n لسنوات، وبعد الاستثمار المستمر في البحث والتطوير والتجريب، أصبحت جاهزة أخيرًا للإنتاج الضخم. للتحقق من أداء توليد الطاقة للمنتج، أطلقت JA Solar و TÜV NORD اختبارًا لعائد الطاقة لمدة عام واحد (فبراير 2021 – فبراير 2022) في مركز اختبار الفولطا الضوئية الصيني، قاعدة ينشوان (شمال غرب الصين). تُظهر النتائج أن إنتاجية الطاقة للوحدة النمطية من النوع n بناءً على خلايا Bycium + أعلى بنسبة 3.9% من تلك الخاصة بوحدات p-PERC النمطية. وفقًا لبيانات محاكاة نظام JA Solar الكهروضوئي، مقارنة بالوحدات من النوع p ، فإن خفض تكلفة BOS لـ DeepBlue 4.0 X يصل إلى 2.1%، و LCOE عند 4.6%، مما يزيد من IRR ويجلب المزيد من القيمة للعميل.

وقال السيد شينوي نيو، عضو مجلس الإدارة ونائب الرئيس الأول لشركة JA Solar ، “لقد أصبح تطوير الحلول منخفضة الكربون والحلول الخضراء مهمة عالمية رئيسية. وباعتبارها واحدة من أكثر مصادر الطاقة المتجددة مرونة وفعالية من حيث التكلفة، أصبحت الطاقة الكهروضوئية قوة مهمة في تعزيز الحياد الكربوني. من النوع p إلى النوع n ، من DeepBlue 3.0 إلى DeepBlue 4.0 X ، تلتزم JA Solar دائمًا بمفهوم تصميم المنتج “الموجه للعملاء”. ونحن نحاول دائما تحسين أداء الوحدات الكهروضوئية في توليد الطاقة من أجل خلق قيمة أكبر للعملاء وتعزيز تطبيق الطاقة الكهروضوئية على نطاق عالمي للاضطلاع بدور أكبر في عملية الحياد الكربوني العالمي”.

الصورة –  https://mma.prnewswire.com/media/1820491/JA_Solar_new_product_DeepBlue_4_0_X.jpg

Posted on

‫Petal Maps تجلب تجربة الملاحة للحياة مع إصدار HUAWEI Mate Xs 2 الجديد كليًا

·  يُقدم الجمع بين الأجهزة والبرامج الفائقة معًا للمستخدمين تجربة ملاحة أكثر وضوحًا وتأثيرًا

ميلان، 19 مايو 2022 / PRNewswire / — أصدرت شركة هواوي رسميًا الهاتف القابل للطي HUAWEI Mate Xs 2 في ميلان في 18 مايو 2022. يُقدم هاتف HUAWEI Mate Xs 2 الذي أُصدر حديثًا مزيجًا مثاليًا من التكنولوجيا القوية وتجربة مستخدم مُحسنة على تطبيقات HMS . وتكيف تطبيق الخرائط الحصري من هواوي Petal Maps مع هذا الهاتف الذكي الجديد. وتوفر قدرات المرونة والتوسعة للشاشة القابلة للطي للمستخدمين تجربة ملاحة أكثر وضوحًا وتأثيرًا، مما يجعل السفر أكثر سلاسة من أي وقت مضى.

عِش تجربة التنقل غير المُعتاد في Petal Maps لحدود أبعد مع شاشة HUAWEI Mate Xs 2 الأكبر حجمًا

تتيح الشاشة الأكبر للمستخدمين الاطلاع على المزيد من المعلومات في آن واحد، وتسمح بملاحة إضافية تساعدك على تحديد المواقع والتوجيه بالأسهم في Petal Maps ، مما يوفر ملاحة أكثر وضوحًا وتأثيرًا.

Petal Maps brings the navigation experience to life with the all-new HUAWEI Mate Xs 2

كما تتيح Petal Maps للمستخدمين، أثناء تنقلهم، الاستمتاع برؤية أفضل للطرق التي يسلكونها، مع معلومات خاصة بتحديد الموقع والتوجيه بالأسهم. ويُجهز ذلك المستخدمين حتى يتمكنوا من اتخاذ القرارات الهامة مقدمًا، كالدوران، أو الصعود على منحدر، أو المرور عبر مُفترق طرق بأمان.

ويمكنك بالإضافة إلى ذلك أثناء القيادة، فتح الشاشة بسهولة ووضعها بوحدة التحكم المركزية لمركبتك. ستعمل شاشة الهاتف القابلة للطي على نحو مماثل كوحدة تحكم مركزية للسيارة للحصول على عرض للملاحة أكثر سلاسة ونبضًا بالحياة أثناء تجولك في الشوارع.

وتتيح لك Petal Maps في HUAWEI Mate Xs 2 العمل على أي حجم للشاشة يُناسبك بشكل أفضل – ويمكنك طي الشاشة وفتحها بناءً على تفضيلاتك لشاشة تنقل أصغر أو أكبر حجمًا، وسواء كنت تقود أو تمشي.

Petal Maps توفر تحسينات لواجهة المستخدم وتجربته فيما يخص مستخدمين الشاشة الأكبر لهاتف HUAWEI Mate Xs 2

تُعطي Petal Maps دائمًا الأولوية لجعل تفاعلات المستخدم ممتعة وجذابة قدر الإمكان، وتطبيق واجهة مُبسطة، وإنتاج ألوان أكثر سطوعًا وواقعية، والتدعيم على مستوى الشارع وكذلك بالنسبة للتفاصيل المعمارية، وتقديم إضاءة واقعية على مستوى ثلاثي الأبعاد.

كما يتضمن التطبيق طبقات خرائط، مثل الخرائط ثلاثية الأبعاد لإعادة خلق فروق دقيقة لحالات العالم الواقعي على الشاشة. وتُبرز شاشة الخرائط ثلاثية الأبعاد مستوى أكثر شمولًا من حيث التفاصيل. وسيتمكن المستخدمون من رؤية أضواء الشوارع وأضواء المباني بالوضع المظلم عند التنقل ليلًا باستخدام تأثيرات الإضاءة الواقعية.

Petal Maps brings the navigation experience to life with the all-new HUAWEI Mate Xs 2

وتعمل الشاشة الأكبر للهاتف على تحسين الطبقة ثلاثية الأبعاد الغنية بالتفاصيل، مع عناصر كالطقس، وأوقات اليوم، وتأثيرات الإضاءة المرئية على Petal Maps ، مما يجلب رؤى جديدة للعيان.

وتتضمن الطبقة ثلاثية الأبعاد الآن، إضافة إلى ذلك، معالم بارزة مثل برج إيفل، وعجلة لندن، وبرج كوالالمبور، وأُصدرت جميعها على نظام ثلاثية الأبعاد بحيث يمكن للمستخدمين السفر حول العالم في مخيلتهم، دون الحاجة حتى لأن يخطو خطوة للخارج.

واُعترف بتجربة تفاعل واجهة المستخدم الرائدة بذلك التطبيق، كما مُنحت Petal Maps جائزة Red Dot Design المرموقة. ويتميز بتصميم تجربة مُستخدم فائقة وإعادة إنتاج الألوان، ويوفر مرئيات مُبسطة وعمليات سلسة وتبديلًا سلسًا للصفحات للحصول على مستوى غير مسبوق من التأثير عند فتح التطبيق.

تقدم التطبيق بسرعة فائقة، واستمر في الازدهار في عام 2021. طبق مبدعو التطبيق إدارة سلسلة ألوان احترافية وإعادة إنتاج HUAWEI Mate Xs 2 لضمان إعدادات تلتقط جمال العالم الحقيقي بالخرائط على الشاشة، مع الحفاظ على وضوحها، وإمكانية الوصول إليها.

Petal Maps تستمر في إنشاء تجربة مستخدم أكثر ثراءً وواقعية

التزمت Petal Maps ، منذ انطلاقها في أكتوبر 2020، برؤية إنشاء “طريقة جديدة لاستكشاف العالم”، مما يوفر ميزات ملاحية رائدة أثارت الجدل . وأُصدرت Petal Maps بالفعل في أكثر من 160 بلدًا ومنطقة بجميع أرجاء العالم، وحظيت بأكثر من 28 مليون مستخدم نشط شهريًا، فضلًا عن الإشادة على نطاق واسع.

أطلقت Petal Maps العديد من الميزات المفيدة لزيادة تحسين تجربة المستخدم. وتتيح لك Petal Maps العثور على طريقك بسلاسة بفضل التحسينات المفيدة مثل دليل تحديد الموقع (Lane Guidance) ، والتي تساعد المستخدمين على تحديد سيناريوهات الطرق وحركة المرور المعقدة والتنقل بها، ووظيفة الخرائط غير المتصلة بالإنترنت (Offline Maps) ، والتي تمكن Petal Maps من استخدام إمكانية الوصول المحدود للإنترنت.

بالإضافة إلى ذلك، أصدرت Petal Maps مؤخرًا الكثير من الميزات الجديدة المثيرة للاهتمام، كشكل الواجهة الشخصية المُخصص للفصول الأربعة، وطبقات درجة الحرارة وهطول الأمطار. يمكن للمستخدمين تبديل الواجهات بناءً على تفضيلاتهم الشخصية، وعرض التغييرات المستقبلية لدرجة الحرارة وهطول الأمطار باستخدام التأثير البصري للخريطة.

وتواصل Petal Maps ، مُتطلعة للمستقبل، الارتقاء بتجربة الذكاء الاصطناعي السلسة في جميع السيناريوهات من خلال التعاون القوي بين الأجهزة والبرامج القوية كهذه التجربة، مما يجلب تجارب مستخدمين أكثر ثراءً وابتكارًا للمستهلكين في جميع أنحاء العالم.

(ربما يختلف توافر ميزات HUAWEI Mate Xs 2 و Petal Maps باختلاف البلدان أو المناطق، ويجب نشرها بالظروف الفعلية ).

إذا كنت ترغب في معرفة المزيد عن Petal Maps ، تفضل رابط التنزيل المباشر الخاص بتطبيق Petal Maps :    https://petalmaps.dre.agconnect.link/pvB6pK 

الصورة – https://mma.prnewswire.com/media/1819666/1.jpg  
الصورة – https://mma.prnewswire.com/media/1819614/image_5022671_31868493.jpg